Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - August 2014


Mass Spectrometry Principles and Practice

04 Aug 2014 - 08 Aug 2014 - Stockton, CA, USA



Bookmark and Share


This unique, 5-day lecture and hands-on laboratory course is the most comprehensive training available for the analyst using chromatography / mass spectrometry. Taught by a team of expert instructors, participants will leave with an understanding of key mass spectrometry principles, practical lab experience, and reference materials, enabling them to put their newly-acquired knowledge into use immediately. Instruments from the world’s leading mass spectrometry vendors are used in the course, giving attendees the opportunity to obtain hands-on experience with state-of-the-art instrumentation. The lab experiments are real-life, practical exercises that reinforce the fundamental concepts presented in lecture. Participants work in teams to conduct exercises, interpret experimental data and present their results. The course is a true collaborative learning experience—students are encouraged to ask questions and learn from each other, as well as the instructors. Who Should Attend: Scientists and analysts wishing to quickly deepen their practical LC/MS and GC/MS knowledge and experience Class size is limited to 26 students, so REGISTER NOW to ensure your spot. Partial List of Topics Covered: • Operating basics of LC/MS and GC/MS and ionization techniques • Mass spectral interpretation strategies • Practical advice on operating and maintaining mass spectrometers • Designing and optimizing GC/MS and LC/MS methods and experiments • Using computer tools to analyze LC/MS, GC/MS and MS/MS data Course Location: University of the Pacific, Stockton, California (near San Francisco/Oakland/Sacramento)

Further information
Scientific News
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!